Informatics and modeling challenges in fragment-based drug discovery.
about
Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-d-erythritol kinase - ligand recognition in a template for antimicrobial drug discoveryMolecular docking and ligand specificity in fragment-based inhibitor discoveryDocking for fragment inhibitors of AmpC -lactamaseDeciphering the Arginine-binding preferences at the substrate-binding groove of Ser/Thr kinases by computational surface mappingProtein pockets: inventory, shape, and comparisonFragment approaches in structure-based drug discoveryHTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.
P2860
Q27650391-97F0A164-7E99-49DD-873C-E73AF4D7F894Q27654237-F91C7B76-5360-4E7C-B8E5-2A25CB139F23Q27655382-2C5B4239-03E5-4617-8AA1-8461C06E8775Q28478059-E5016EC3-0540-47A3-A7EF-A976D5CDBF42Q30494235-24A995EC-FBAA-46ED-A1BE-482946D595DFQ33329074-A78A2221-E81F-464E-A790-C1F5F5A70108Q49874343-0502E5EC-16E3-41E0-AC51-9CF44E149B7E
P2860
Informatics and modeling challenges in fragment-based drug discovery.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Informatics and modeling challenges in fragment-based drug discovery.
@ast
Informatics and modeling challenges in fragment-based drug discovery.
@en
Informatics and modeling challenges in fragment-based drug discovery.
@nl
type
label
Informatics and modeling challenges in fragment-based drug discovery.
@ast
Informatics and modeling challenges in fragment-based drug discovery.
@en
Informatics and modeling challenges in fragment-based drug discovery.
@nl
prefLabel
Informatics and modeling challenges in fragment-based drug discovery.
@ast
Informatics and modeling challenges in fragment-based drug discovery.
@en
Informatics and modeling challenges in fragment-based drug discovery.
@nl
P2093
P1476
Informatics and modeling challenges in fragment-based drug discovery
@en
P2093
Roderick E Hubbard
P304
P577
2007-05-01T00:00:00Z